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Abstract  
This paper describes the development and application of a biosensor for the 
amperometric measurement of galactose, in the presence of human hepatocellular 
carcinoma cells, with and without the presence of a hepatotoxic agent. The biosensor 
was fabricated by first drop-coating 1.5 % cellulose acetate onto a 3 x 3 mm screen-
printed carbon electrode. This was followed by depositing 2 U of galactose oxidase. 
Using gloss finish paint and a valox card to define the electrode area, the dimensions 
were reduced to 3 mm x 0.5 mm. Hepatocellular carcinoma cells were utilised for in 
vitro toxicity testing, by evaluating the effect of paracetamol on galactose uptake. 
The amperometric responses to galactose indicated that the level of inhibition of 
uptake was directly proportional to the concentration of paracetamol after 24 hours 
of exposure to the hepatocellular carcinoma cells. These results demonstrate that the 
fabricated biosensor may be used for the real-time monitoring cell metabolism and 




There is a considerable interest in using cell-based assays, ie. experiments based on 
the use of live cells, for screening the toxicity of chemical compounds, particularly 
in the pharmaceutical industry. These include a variety of techniques for measuring 
cell proliferation, morphology, viability, cytotoxicity, and motility (Keese and 
Giaever 1994; Riss, O'Brien and Morvec 2003; Nabhan 2003). Whereas cell viability 
assays generally involve measuring the number of live cells, cytotoxicity assays tend 
to evaluate the number of dead cells.  Both types of cell-based assay are routinely 
used for drug discovery using high-throughput screening, environmental assessment 
of relevant chemical compounds, and as biosensors for cellular behaviour analysis 
(Ehret et al 1997; White 2000; Shuileabhain et al 2004). In 2003, Nabhan discovered 
that over 30 % of prospective candidate drugs fail toxic verification. Consequently, 
cytotoxicity testing in different cell types has become one of the fundamental tools 
for drug discovery (Riss, O'Brien and Morvec 2003; White 2000). Hepatotoxicity is 
a major concern in drug testing as most toxic effects observed are by drugs that are 
metabolised by the liver; thus liver cells have been utilised by many drug discovery 
and development laboratories (Anderson et al 1996; Li et al 1999; Ni et al 2001; 
Valentin et al 2001). 
Cultured hepatocytes are routinely used to evaluate the toxicity of chemical 
compounds (Groneberg, Grosse-Siestrup and Fischer, 2002; Gomez-Lechon, Castell 
and Donato 2007; Horii and Yamada 2007).  Hepatocellular carcinoma cells have 
been used to screen complex mixtures, in addition to screening individual chemical 
compounds for potential hepatotoxic effects.  Assays using these cells have been 
used successfully to provide data for determining potential mechanisms of liver 
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toxicity (Kelly and Sussman 2000; Flynn and Ferguson 2008; Li and Chan 2009; 
Prot 2011). 
Hepatotoxicity screening methods commonly used include the adenosine 
triphosphate assay, the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium 
bromide assay and the neutral red dye uptake assay (Li et al 1999; Ni et al 2001; 
Valentin et al 2001; Groneberg, Grosse-Siestrup and Fischer (2002). However, 
nearly all of such traditional biochemical techniques are laborious, time consuming 
and tend to involve complex procedures with multiple reagents. For in vitro 
experiments these techniques are incapable of providing quantitative data without 
affecting the target cells.  This makes it extraordinarily difficult to monitor 
continuous toxic effects or to analyse real-time changes in cell viability. 
Consequently, numerous research studies have focused on developing alternative 
methods that allow for continuous monitoring of toxic effects (Wolf et al 1998; 
Wegener, Janshoff and Galla 1998; Wegener et al 1999; Wegener, Keese and 
Giaever 2000; Sohn et al 2000; Phelps and Depaola 2000; Xiao et al 2002; Xiao and 
Luong 2003). 
An alternative electrochemical analytical approach, based on amperometric 
measurements using fabricated electrodes, may provide the ideal method for 
detecting hepatotoxicity with multiple reagents. The possibility of obtaining useful 
metabolic data from cell-based assays in conjunction with amperometry has been 
recently investigated by our group (Pemberton et al 2009; 2010). In these studies, 
electrochemical microband biosensors incorporating a relevant enzyme, were 
successfully utilised to continuously and selectively monitor glucose or lactate. The 
biosensors could maintain steady-state current responses under quiescent solution 
conditions and could operate in culture medium for batch-type analysis to monitor 
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the depletion of glucose by hepatocytes in a cell density-dependent manner 
(Pemberton et al 2011). The ability to sustain amperometric current responses over 
several hours provides the possibility of utilising the biosensors for real-time toxicity 
monitoring. 
Numerous methods for the fabrication of electrodes have been developed and this 
has led to the manufacture of miniaturised, reproducible and inexpensive devices. 
Among these, the method of screen-printing is well-documented (Wring and Hart 
1992).  Screen-printing is a low-cost process, particularly when carbon ink is used, 
and it has been widely utilised to manufacture electrodes for developing biosensors. 
The screen-printing process is simple, fast and allows for the printing of electrodes 
with different geometries (Wring and Hart 1992). In the present paper, galactose 
biosensors were fabricated, designed and developed utilising a water-based carbon 
ink formulation.  The formulation and the first part of the procedure have been 
described previously for the fabrication of macroelectrode galactose biosensors for 
use in serum analysis (Kanyong et al 2013).  The present paper describes a modified 
procedure for the fabrication of microband galactose biosensors. The ability to 
obtain steady-state responses in quiescent phosphate buffer solutions was 
investigated using these biosensors. The operation of the galactose biosensor was 
also investigated in culture medium. Further studies, utilising the galactose 
biosensor, were conducted to detect the uptake of galactose by the mammalian 
hepatocellular carcinoma liver cell line at 37°C, over a period of 24 hours. The effect 
of paracetamol, a model hepatotoxic compound, on galactose uptake by 
hepatocellular carcinoma cells was investigated. The results of this study and 




Materials and methods 
Chemical and reagents 
All chemicals including acetone, sodium chloride, high-glucose (4.5 g/L)-
supplemented Dulbecco’s Modified Eagle’s medium (DMEM, D5796-500ML), 
penicillin and streptomycin sulphate were of analytical grade, purchased from Sigma 
Aldrich, Dorset, UK. 50 mM phosphate buffer was prepared by combining 
appropriate amounts of tri-sodium phosphate dodecahydrate, sodium dihydrogen 
orthophosphate dehydrate and disodium hydrogen orthophosphate dehydrate to yield 
the desired pH. Cellulose acetate (Catalogue number: 3782; LOT: 29F0024), D-(+)-
galactose (Lot#: 021M00041V, Code: 1001033250) and galactose oxidase (G7400, 
from Dactylium dendroides), were obtained from Sigma Aldrich, Dorset, UK. Fetal 
Bovine Serum (Cat #: S1810-500; Lot #: S06015S1810) was purchased from 
Biosera, East Sussex, UK and stored in small aliquots at -22 °C. White gloss finish 
paint and brush were purchased from B&Q, Avon, UK. Cellulose acetate was 
dissolved in acetone following up to 2 minutes sonication. 
Hepatocellular carcinoma cell culture 
The hepatoma cell line, HepG2, (obtained from the European Collection of Animal 
Cell Cultures) was cultured as a monolayer in 75 cm
2
 flasks in a 5 % CO2-in-air 
atmosphere at 37 °C with an initial density of 10
5
 cells/ml in15 ml of medium. The 
medium was high-glucose DMEM containing 10 % foetal bovine serum, 1 % 
nonessential amino acids, 2 mM L-glutamine and 100 U/ml penicillin and 100 µg/ml 
streptomycin (pen + strep). When the cells were confluent, known concentrations of 
galactose and paracetamol were added to the flasks, which were then incubated for a 
further 24 hr. 
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Apparatus and measurements 
All electrochemical measurements were conducted with a three-electrode system, 
consisting of a cobalt phthalocyanine screen printed working electrode (GEM code: 
C40511D8), Ag/AgCl reference electrode (GEM Product Code: C61003P7) both 
screen-printed onto valox (a semi-crystalline material based on polybutylene 
terephthalate and polyethylene terephthalate polymers; Cadillac Plastics Ltd. 
Swindon, UK) and a separate Pt wire counter electrode. The area of the working 
electrode was defined using insulating tape (RS, Northants, UK) to define a 3 x 3 
mm square area.  
The working and reference electrodes were connected to the potentiostat with gold 
clips. An Autolab Electrochemical Analyser with General-Purpose Electrochemical 
Software (Version 4.9, Netherlands) was used for the acquisition of data and 
experimental control, with a 10 ml electrochemical cell inside a water jacket for 
electrochemical measurements. Data was further analysed with Microsoft Excel. 
Weighing was carried out with a Precisa precision balance 262SMA-FR purchased 
from Milton Keynes, Buckinghamshire, UK. Measurement and monitoring of pH 
was conducted with a Fisherbrand Hydrus 400 pH Meter (Orion Research Inc., 
USA). Sonications were performed with a Devon FS100 sonicating water bath 
(Ultrasonics, Hove, Sussex, UK). The temperature was controlled with a 
thermostated water bath (Thermo Scientific HAAKE DC10-P5/U unit). The 
dimensions of the valox card were measured using a TESA micrometer obtained 
from Radio Spares, Switzerland. 
Procedures  
Biosensor preparation:  
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(i) Immobilization of reagents onto the working area of a cobalt phthalocyanine 
screen printed working electrode   
The base unmodified cobalt phthalocyanine screen-printed electrode transducer was 
prepared using a water-based ink and the sensors were screen-printed in groups of 
six onto valox as previously described by Crouch et al (2005).  The cobalt 
phthalocyanine screen printed electrode was modified by drop-coating 5 µl of 1 % 
cellulose acetate in acetone directly onto the exposed 9.0 mm
2
 working electrode and 
allowed to dry. The electrodes were then coated with 5 µl of galactose oxidase 
solution containing the appropriate number of units and left to air-dry. Dummy 
biosensors were prepared using the same procedure, except that the enzyme was 
substituted for the same mass of bovine serum albumin (BSA), as described 
previously (Kanyong et al 2013). 
(ii) Definition of a microband working electrode area  
After drying, the side of a valox card with dimensions of 18 mm x 500 µm was 
carefully vertically fixed onto the working area of the electrode with an adhesive. 
White gloss finish paint was then drop-coated onto the working surface to cover the 
enzyme layer to each side of the vertically fixed valox card and allowed to dry. Once 
dry, the valox card was carefully removed to expose a 3 mm x 500 µm working 
electrode area.  A schematic of the final biosensor is shown in Figure 1.  
Once prepared, the galactose biosensors were stored at 4 °C in a vacuum desiccator 
containing silica gel, until ready for use. The same procedure was used to obtain 
dummy biosensors, by using the same mass of BSA as that of the enzyme; any 
responses resulting from these devices were subtracted from the biosensor response.  
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Calibration studies by amperometry in standard solutions      
Calibration plots for the proposed galactose biosensor were obtained by immersing 
the electrode in 10 ml of 50 mM phosphate buffer solution containing 50 mM NaCl, 
or 10 ml DMEM for subsequent tests. A potential of +0.5 V vs. Ag/AgCl was 
applied to the working electrode and the system was left for the current response to 
reach steady-state. Using a micropipette, a series of small additions of standard 
galactose solution was made, awaiting steady-state responses between additions. 
Calibration plots were constructed by plotting each current response against the final 
cell galactose concentration. Mean current responses of three replicates were 
calculated. 
Evaluation of the toxic effect of paracetamol on galactose uptake by 
hepatocellular carcinoma cells 
A ten millimolar (10 mM) concentration of galactose and either 5 µM, 50 µM, 500 
µM or 1000 µM concentrations of paracetamol were incubated in flasks with 15 ml 
of DMEM containing hepatocellular carcinoma cells for 24 hours. At the start of the 
experiments, each culture medium contained 10 mM galactose. After the 24-hr 
incubation period, the current responses due to remaining galactose were measured 
by amperometry using the galactose and dummy biosensors in quiescent solution. 
Any responses resulting from the dummy electrode devices were subtracted from the 
biosensor response. Consequently, the uptake of galactose following the 24-hr 
incubation period could be estimated. The current responses obtained at 8000 
seconds were used to describe the uptake of galactose by the cells as well as the 





Results and Discussion 
Sequences of reactions in the operation of the galactose biosensor  
The analytical response for galactose occurs as a result of the enzymatic and 
electrocatalytic processes. Hydrogen peroxide is generated during the enzymatic 
conversion of galactose to D-galacto-hexodialdose in the presence of galactose 
oxidase and oxygen. Hydrogen peroxide is electrocatalytically oxidised at the cobalt 
phthalocyanine screen printed electrode, which constitutes the analytical response. 
This response is directly proportional to the original concentration of galactose.  
Calibration studies by amperometry in standard solutions 
The effects of enzyme loading (1.2 - 3 U), temperature (25 - 40 C), pH (5.0 - 10.0), 
the ionic buffer strength (0.025 - 0.45 mM) on the analytical performance of the 
biosensor have previously been published (Kanyong et al, 2013). The optimal 
biosensor performance occurred with a loading of 2 U of galactose oxidase, at 35°C, 
50 mM phosphate buffer (pH 7.0). Calibration studies were performed with the 
optimised galactose over the concentration range of 1.98 mM – 9.52 mM in 
phosphate buffer solution under quiescent conditions. A fresh biosensor was used 
with each measurement which was performed in triplicate for each galactose 
concentration.  
As can be seen from the amperometric responses shown in Figure 2, each galactose 
addition elicited a rapid current response.  A calibration study was conducted over a 
wide concentration range (1.98 – 18.18 mM) and from this plot, the linear range was 
observed to be between 1.98 and 9.52 mM.  The limit of detection based on S/N = 3, 
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 with a linear range up to 9.52 mM and a precision (coefficient of 
variation; CV) for replicate biosensors of 1.3 % in buffer solution. These 
performance characteristics  demonstrate that the galactose biosensor is able to give 
concentration dependent, steady-state current responses in quiescent solutions.  
Consequently, the biosensor performance was then evaluated in culture medium 




 with a linear 
range up to 9.52 mM and a precision (CV) for replicate biosensors of 1.2 %. Clearly, 
the sensitivity of the galactose biosensor in culture medium has been reduced by ~50 
% of its sensitivity in buffer solution. However, its overall analytical performance in 
culture medium was considered satisfactory for end-point measurements of galactose 
in culture medium. 
Evaluation of the toxic effect of paracetamol on galactose uptake by 
hepatocellular carcinoma cells   
The biosensor’s ability to measure galactose uptake in cell culture was examined 
using cell culture supernatants obtained from hepatocellular carcinoma cells. The 
cells were incubated in 15 mls of culture media containing 10 mM galactose and 
varying concentrations (5, 50, 500 or 1000 µM) of paracetamol for 24 hours. 
It is well known that cells use glucose as their primary source of energy. It is also 
worth noting that the depletion of glucose by healthy cells occurs most rapidly 
during the first 4 hours of growth and continues up to about 10 hours (Pemberton et 
al 2011). In the absence of glucose, it is expected that the cells would begin to 
deplete the 10 mM galactose that was added to the culture medium. As can be seen 
in Figure 3, there was complete galactose uptake by the hepatocellular carcinoma 
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cells in the absence of paracetamol. The current of 90 nA for 10 mM galactose was 
reduced to baseline levels after the 24h period, indicating that all of the galactose had 
been consumed by the cells.  An estimate of galactose consumption over 24 h, based 
on initial cell numbers present, indicates uptake of 150 micromoles by 1.5 x 10
6 
cells, or 100 picomoles of galactose per cell.  In the presence of paracetamol, 
galactose current responses were reduced, indicating inhibition of cell uptake.  
Paracetamol toxicity appeared to be dose-dependent as shown in Fig.3.  In the 
presence of paracetamol at 1000, 500, 50 and 5 M, galactose uptake was inhibited 
by 99%, 60%, 20% and 12% respectively.  Similar inhibition of glucose uptake was 
observed in the presence of 1000 µM paracetamol by Pemberton et al. (2011) using 
a glucose biosensor.  
Conclusions  
An amperometric galactose biosensor was developed and characterised in both 
phosphate buffer and culture medium. In culture medium, the galactose biosensor 




, a linear range up to 9.52 mM and a CV 
of 1.2 %. This performance was considered satisfactory in evaluating the effect of 
paracetamol, a model hepatotoxic compound, on galactose uptake by hepatocellular 
carcinoma cells. Paracetamol toxicity appeared to be dose-dependent and these 
findings correlate with inhibition profiles observed by Xu, Ma and Purcell (2003) for 
glucose uptake in the presence of 1000 µM paracetamol. This suggests that the 
amperometric galactose biosensor could be used for real-time monitoring of 
galactose metabolism to provide additional information on metabolic events. In the 
future, an array system incorporating screen-printed microelectrode biosensors for a 
variety of biomarkers, in a multi-well configuration, would be a viable option for 
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mammalian cell toxicity testing. The latter has the additional potential for the 
replacement or reduction of animal testing.  
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Figure Captions  
Figure 1: Schematic representation of the proposed galactose biosensor.  
Figure 2: Typical amperometric responses obtained with the galactose biosensor on 
exposure to various concentrations of standard galactose solutions: 1.98, 4.88 and 
9.52 respectively in unstirred 10 ml of 50 mM phosphate buffer solution (pH 7.0) 
containing 50 mM NaCl at an applied potential of + 0.5 V.The arrows show the 
points at which additions of galactose are made to the cell.  
Figure 3: Bar graph illustrates the current responses for each of the 24-hr 
supernatants obtained from cell cultures containing HepG2 cells in 15 ml volumes 
and incubated with 10 mM galactose and either 5, 50, 500 or 1000 µM paracetamol. 
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